Should a subdermal (under the skin) contraceptive implant be removed in a female patient of reproductive age due to severe side effects?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Should a Subdermal Contraceptive Implant Be Removed Due to Side Effects?

If the patient desires removal due to side effects at any time, remove the implant immediately, offer counseling on alternative contraceptive methods, and initiate another method if desired. 1

Patient-Centered Decision Making

The decision to remove a contraceptive implant should be driven entirely by the patient's tolerance of side effects and desire for continued use, not by provider judgment about whether side effects are "severe enough." 1

Immediate Removal Indications

  • Patient request is sufficient justification - No minimum threshold of side effect severity is required for removal 1
  • Remove the implant if the patient wants it out, regardless of provider assessment of side effect severity 1
  • Delays in removal after patient request can cause frustration and undermine trust in contraceptive counseling 2

Common Side Effects Leading to Removal

Bleeding Irregularities (Most Common)

  • Unscheduled spotting or light bleeding is common with implant use and generally not harmful 1
  • Heavy or prolonged bleeding is uncommon but can occur 1
  • Bleeding irregularities are the most frequently cited reason for early removal 2
  • Before attributing bleeding to the implant, rule out underlying conditions: medication interactions, STDs, pregnancy, thyroid disorders, or new uterine pathology (polyps, fibroids) 1

Other Hormonal Side Effects

  • Weight gain (reported by 54.76% of users in one study) 3
  • Mood swings, headaches 2
  • Often a combination of factors reaches a "tipping point" where negative experiences outweigh benefits 2

Management Algorithm Before Removal

Step 1: Explore Patient Goals

  • Determine if patient wants continued use (with or without treatment), or removal 1
  • Provide reassurance that contact is available anytime for side effects 1

Step 2: If Patient Wants Treatment (Not Removal)

For spotting or light bleeding:

  • NSAIDs for 5-7 days (treatment may be repeated as needed) 1

For heavy or prolonged bleeding:

  • NSAIDs for 5-7 days 1
  • Hormonal treatment (e.g., low-dose combined oral contraceptives or estrogen) for 10-20 days 1
  • Antifibrinolytic agents (e.g., tranexamic acid) for 5 days 1
  • Treatments with persistent effects: NSAIDs (celecoxib, ibuprofen, mefenamic acid) for 5-7 days, or SERMs (tamoxifen) for 7-10 days 1

Step 3: If Patient Wants Removal

  • Remove immediately - do not attempt to convince patient to continue 1, 2
  • Offer counseling on alternative methods 1
  • Initiate another contraceptive method if desired 1

Alternative Contraceptive Options After Removal

Highly Effective Alternatives (Pregnancy Rate <1% per year)

  • Copper IUD or levonorgestrel IUD - equally effective as implant, different side effect profile 1
  • Another subdermal implant (if side effects were tolerable and removal was for other reasons) 1

Effective Alternatives (Pregnancy Rate 3-8% per year)

  • Combined estrogen-progestin methods 1
  • Depot medroxyprogesterone acetate (DMPA) injections 1
  • Progestin-only pills 1

Critical Counseling Pitfall

Many women feel insufficiently warned about possible side effects before insertion 2. This contributes to dissatisfaction and early removal. When counseling about implant insertion initially, comprehensive discussion of bleeding irregularities and other hormonal side effects is essential to set realistic expectations 1, 2.

Special Consideration: Pregnancy with Implant

If pregnancy occurs with implant in place:

  • Confirm pregnancy and establish gestational age 4
  • Evaluate for ectopic pregnancy (though risk is not increased with implants) 4
  • Remove implant as soon as possible if patient desires to continue pregnancy 4
  • Unlike IUDs, implant removal does not improve pregnancy outcomes, but removal is still recommended 4

Bottom Line

Supporting women's contraceptive choice means accepting that some women cannot tolerate the implant, and encouraging retention without addressing distressing side effects is counterproductive. 2 Remove the implant when requested, provide alternative options, and maintain the therapeutic relationship for future contraceptive needs.

Related Questions

What are the common signs and symptoms associated with subdermal contraceptive implants in female patients of reproductive age?
What are the criteria for removing a subdermal contraceptive implant before its expected lifespan?
How do I switch from a monthly injectable contraceptive to a subdermal implant?
When should I start using the injectable hormonal contraceptive (e.g. Depo-Provera (medroxyprogesterone acetate)) after removing the subdermal implantable contraceptive?
How long will a subdermal implant (containing etonogestrel), such as Nexplanon (etonogestrel), remain effective in a female of reproductive age with no specified medical history if removed before its due date?
What tumor markers should be obtained for a patient with biliary ectasia, specifically to monitor for potential malignancies such as cholangiocarcinoma?
Is it safe to start enoxaparin (low molecular weight heparin) 8 hours after the last dose of dabigatran (Pradaxa) in a patient with a history of deep vein thrombosis (DVT) and elevated body mass index (BMI)?
What are the next steps for an older adult patient with impaired renal function, as indicated by a Blood Urea Nitrogen (BUN) level of 11 and a creatinine level of 131, resulting in a BUN/creatinine ratio of 21?
What are the behavioral characteristics of a Bandicoot rat infected with rabies?
Can adding buspirone (an anxiolytic) and memantine (NMDA receptor antagonist) to a patient's current medication regimen help regulate mood and anxiety, manage obsessive-compulsive disorder (OCD), mitigate sexual side effects, emotional blunting, and fatigue in a patient with a complex psychiatric history, who is unable to tolerate vilazodone or bupropion due to insomnia and increased aggression, and has a genetic indication against escitalopram?
What is the best course of action for a patient who develops a new Deep Vein Thrombosis (DVT) while on dabigatran (Pradaxa) and has normal renal function, considering their elevated Body Mass Index (BMI)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.